V
Viraj A. Master
Researcher at Emory University
Publications - 453
Citations - 8922
Viraj A. Master is an academic researcher from Emory University. The author has contributed to research in topics: Medicine & Renal cell carcinoma. The author has an hindex of 44, co-authored 346 publications receiving 7023 citations. Previous affiliations of Viraj A. Master include Centers for Disease Control and Prevention & San Francisco General Hospital.
Papers
More filters
Journal ArticleDOI
An intra-tumoral niche maintains and differentiates stem-like CD8 T cells
Caroline S. Jansen,Nataliya Prokhnevska,Viraj A. Master,Martin G. Sanda,Jennifer W Carlisle,Mehmet Asim Bilen,Maria Cardenas,Scott Wilkinson,Ross Lake,Adam G. Sowalsky,Rajesh M. Valanparambil,William H. Hudson,Donald J. McGuire,Kevin Richard Melnick,Amir Ishaq Khan,Kyu Seo Kim,Yun Min Chang,Alice Kim,Christopher P. Filson,Mehrdad Alemozaffar,Adeboye O. Osunkoya,Patrick Mullane,Carla LaShannon Ellis,Rama Akondy,Se Jin Im,Alice O. Kamphorst,Adriana Moon Reyes,Yuan Liu,Haydn T. Kissick +28 more
TL;DR: The authors examine the immune cell infiltrates of human tumours and provide evidence for a population of CD8 T cells with stem-cell characteristics and proliferative capacity that reside in an antigen-presenting niche within tumours.
Journal ArticleDOI
Active Surveillance for the Management of Prostate Cancer in a Contemporary Cohort
Marc A. Dall'Era,Badrinath R. Konety,Janet E. Cowan,Katsuto Shinohara,Frank Stauf,Matthew R. Cooperberg,Maxwell V. Meng,Christopher J. Kane,Nanette Perez,Viraj A. Master,Peter R. Carroll +10 more
TL;DR: The authors report their experience in a contemporary cohort of men with prostate cancer who were managed with active surveillance, followed by selective treatment for men who have evidence of disease progression.
Journal ArticleDOI
Frailty and cancer: Implications for oncology surgery, medical oncology, and radiation oncology.
Cecilia G. Ethun,Mehmet Asim Bilen,Ashesh B. Jani,Shishir K. Maithel,Kenneth Ogan,Viraj A. Master +5 more
TL;DR: The concept of frailty has become increasingly recognized as one of the most important issues in health care and health outcomes and is of particular importance in patients with cancer who are receiving treatment with surgery, chemotherapy, and radiotherapy as discussed by the authors.
Journal Article
Initial Experience with the Radiotracer Anti-1-Amino-3-18F-Fluorocyclobutane-1-Carboxylic Acid with PET/CT in Prostate Carcinoma
David M. Schuster,John R. Votaw,Peter T. Nieh,Weiping Yu,Jonathon A. Nye,Viraj A. Master,F. DuBois Bowman,Muta M. Issa,Mark M. Goodman +8 more
TL;DR: Anti-(18)F-FACBC is a promising radiotracer for imaging prostate carcinoma and should be investigated in normal and pathologic tissue and develop a clinical imaging strategy for initial staging and restaging.
Journal ArticleDOI
Too Frail for Surgery? Initial Results of a Large Multidisciplinary Prospective Study Examining Preoperative Variables Predictive of Poor Surgical Outcomes
Louis M. Revenig,Daniel Canter,Maxwell D. Taylor,Caroline G. Tai,John F. Sweeney,Juan M. Sarmiento,David A. Kooby,Shishir K. Maithel,Viraj A. Master,Kenneth Ogan +9 more
TL;DR: In this paper, a preoperative assessment tool (Hopkins Frailty Score) was used to predict 30-day postoperative complications in patients with major general, oncologic, and urologic procedures.